We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLFS icon
3951
BioLife Solutions
BLFS
$1.72B
$13K ﹤0.01%
620
+57
+10% +$1.28K
BOC icon
3952
Boston Omaha
BOC
$421M
$13K ﹤0.01%
546
-1,290
-70% -$32.1K
STEX
3953
Streamex Corp
STEX
$108M
$13K ﹤0.01%
1,127
-64
-5% -$626
CIVB icon
3954
Civista Bancshares
CIVB
$593M
$13K ﹤0.01%
764
+371
+94% +$7.7K
COHN icon
3955
Cohen & Co
COHN
$40M
$13K ﹤0.01%
1,912
+818
+75% +$7.02K
COOK icon
3956
Traeger
COOK
$164M
$13K ﹤0.01%
64
-198
-76% -$35.4K
CRD.B icon
3957
Crawford & Co Class B
CRD.B
$593M
$13K ﹤0.01%
1,710
-1,270
-43% -$7.83K
DUOT icon
3958
Duos Technologies
DUOT
$286M
$13K ﹤0.01%
4,754
+3,894
+453% +$14.2K
ETON icon
3959
Eton Pharmaceutcials
ETON
$1.61B
$13K ﹤0.01%
3,401
-246
-7% -$897
EWCZ
3960
DELISTED
European Wax Center
EWCZ
$13K ﹤0.01%
708
-5,421
-88% -$94.9K
EZPW icon
3961
Ezcorp Inc
EZPW
$1.81B
$13K ﹤0.01%
1,545
-20,504
-93% -$180K
FBIO icon
3962
Fortress Biotech
FBIO
$97.3M
$13K ﹤0.01%
1,047
+986
+1,616% +$11.7K
FFWM
3963
DELISTED
First Foundation Inc
FFWM
$13K ﹤0.01%
1,838
-277
-13% -$3.7K
FIP icon
3964
FTAI Infrastructure
FIP
$533M
$13K ﹤0.01%
4,065
+3,251
+399% +$9.89K
FMB icon
3965
First Trust Managed Municipal ETF
FMB
$2.06B
$13K ﹤0.01%
256
-17
-6% -$864
FVCB icon
3966
FVCBankcorp
FVCB
$338M
$13K ﹤0.01%
1,258
+629
+100% +$8.5K
GALT icon
3967
Galectin Therapeutics
GALT
$347M
$13K ﹤0.01%
6,219
-5,902
-49% -$9.53K
TDAY
3968
USA Today Co
TDAY
$1.03B
$13K ﹤0.01%
7,049
+4,296
+156% +$10.1K
GPRK icon
3969
GeoPark
GPRK
$615M
$13K ﹤0.01%
1,105
-21
-2% -$279
HFFG icon
3970
HF Foods Group
HFFG
$99.2M
$13K ﹤0.01%
3,257
-4,055
-55% -$16.9K
HIFS icon
3971
Hingham Institution for Saving
HIFS
$680M
$13K ﹤0.01%
57
+17
+43% +$4.67K
HONE
3972
DELISTED
HarborOne Bancorp
HONE
$13K ﹤0.01%
1,072
-62
-5% -$829
HRTX icon
3973
Heron Therapeutics
HRTX
$63.9M
$13K ﹤0.01%
8,048
+3,239
+67% +$8.11K
IHRT icon
3974
iHeartMedia
IHRT
$457M
$13K ﹤0.01%
3,406
+2,452
+257% +$15.6K
IMA
3975
ImageneBio Inc
IMA
$66.3M
$13K ﹤0.01%
297
-863
-74% -$39.7K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.